SELFCHECK Cholesterol Test - Data Sheet for HCPs
PRODUCT: SELFCHECK CHOLESTEROL LEVEL TEST
PRODUCT CODE: SC8213
REVISION DATE: 15th August 2025
Test Principle and Specifications
Intended use
The SELFCHECK Cholesterol Test is a manual, quantitative, colorimetric assay for the measurement of total cholesterol level in a finger-prick whole blood sample.
Clinical Context and Limitations
This is a screening test and is not intended for diagnosis. A single test result should not be the sole basis for a clinical decision. The test depends on cholesterol esterase, cholesterol oxidase and peroxidase which activates a colour change in a dye proportional to the level of cholesterol in the blood.
Cholesterol levels may be affected by medication, diet, stress, diabetes, serious illness or pregnancy. In these cases, a delay in testing may give more meaningful results. The following factors are also know to affect results; haemoglobin (>20g/dL), bilirubin (>42mg/dL), high levels of vitamin C (ascorbic acid), alpha-methyl dopa or novalgin. High levels of steroids may also affect the result.
All medical tests, whether used in a hospital laboratory or at home, have limitations and carry a possibility of false positive or false negative results due to individual physiological variations and interpretation of the instructions for use (IFU). This test should be used as one part of a broader approach to health management, including healthcare professionals.
Performance Characteristics
Biomarker
Total cholesterol
Methodology
Colorimetric
Sample type
Finger-prick whole blood sample
International standard
N/A
Cut-off
N/A
Performance vs. laboratory reference method (Reflotron)
Sensitivity: 92.4%
Specificity: 81.3%
Overall agreement: 87.7%
Regulatory and Quality Assurance
Device Classification
In Vitro Diagnostic (IVD) medical device for self-testing, and compliant with the UK Medical Devices Regulations 2002 (as amended).
Conformity Mark
CE marked for self-test use according to the EU In Vitro Diagnostic Directive 98/79 EC (IVDD), including the four-digit number (0483) of the responsible Notified Body. This number is a critical indicator that the device has undergone third-party review specifically for self-test use, distinguishing it from professional-use-only devices used in hospital laboratories and health care professionals. Notified and Approved Bodies are independent, third-party organisations designated by the Competent Authority (MHRA in the UK) to assess the conformity of IVDs to relevant regulations and standards including the IVDD and the In Vitro Diagnostic Regulations.
Regulatory Authority
Registered with the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Quality Management System
Components are assembled in the United Kingdom by J R Biomedical Ltd., at an ISO 13485:2016 certified medical device manufacturing facility, independently audited by UKAS accredited auditors, for the design, development, and manufacture of in-vitro diagnostics. J R Biomedical Ltd (est. 2005), is a developer and supplier of diagnostics to the NHS and medical research laboratories.
Legal Manufacturer
CARE diagnostica Produktions und Vertriebsgesellschaft m.b.H., Traiskirchen, Austria.
UK Distributor
1st Health Products Ltd.
Further information
J R Biomedical Ltd. OpTIC Technology Centre, Wrexham University, St Asaph Business Park, St Asaph, LL17 0JD. United Kingdom.
Telephone 01745 535 169